Skip to main content
Top
Published in: Current Heart Failure Reports 5/2017

01-10-2017 | Management of Heart Failure (T Meyer, Section Editor)

Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient

Authors: Jason A. Chou, Kamyar Kalantar-Zadeh

Published in: Current Heart Failure Reports | Issue 5/2017

Login to get access

Abstract

Purpose of Review

Volume management in hemodialysis patients is often challenging. Assessing volume status and deciding how much fluid to remove during hemodialysis, the so-called ultrafiltration rate (UFR), has remained a conundrum.

Recent Findings

To date there is no objective assessment tool to determine the needed UFR during each hemodialysis session. Higher volume overload or higher UFR is associated with poor outcomes including worse mortality and unfavorable clinical outcomes. We suggest combined use of the following criteria to determine UFR or post-dialysis target dry weight: pre-hemodialysis blood pressure and its intradialytic changes, muscle cramps, dyspnea from pulmonary vascular congestion, peripheral edema, tachycardia or palpitation, headache or lightheadedness, perspiration, and post-dialysis fatigue. Restricting fluid and salt intake—and high-dose loop diuretic use in cases of residual kidney function—can be helpful in controlling fluid gains. More frequent and more severe hypotensive episodes are associated with poor outcomes including higher death risk.
Literature
1.
go back to reference Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clinical journal of the American Society of Nephrology : CJASN. 2010;5:1255–60.CrossRefPubMedPubMedCentral Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clinical journal of the American Society of Nephrology : CJASN. 2010;5:1255–60.CrossRefPubMedPubMedCentral
2.
go back to reference Park J, Rhee CM, Sim JJ, Kim YL, Ricks J, Streja E, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013;84:795–802.CrossRefPubMedPubMedCentral Park J, Rhee CM, Sim JJ, Kim YL, Ricks J, Streja E, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013;84:795–802.CrossRefPubMedPubMedCentral
3.
go back to reference Chazot C, Vo-Van C, Zaoui E, Vanel T, Hurot JM, Lorriaux C, et al. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011;26:2630–4.CrossRef Chazot C, Vo-Van C, Zaoui E, Vanel T, Hurot JM, Lorriaux C, et al. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011;26:2630–4.CrossRef
4.
go back to reference Franz M, Pohanka E, Tribl B, Woloszczuk W, Horl WH. Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl. 1997;59:S39–42.PubMed Franz M, Pohanka E, Tribl B, Woloszczuk W, Horl WH. Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl. 1997;59:S39–42.PubMed
5.
go back to reference Ishibe S, Peixoto AJ. Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice. Semin Dial. 2004;17:37–43.CrossRefPubMed Ishibe S, Peixoto AJ. Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice. Semin Dial. 2004;17:37–43.CrossRefPubMed
6.
go back to reference Lopot F, Kotyk P, Blaha J, Forejt J. Use of continuous blood volume monitoring to detect inadequately high dry weight. The International journal of artificial organs. 19:411–4. Lopot F, Kotyk P, Blaha J, Forejt J. Use of continuous blood volume monitoring to detect inadequately high dry weight. The International journal of artificial organs. 19:411–4.
7.
go back to reference Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G. Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr. 2006;19:356–63.CrossRefPubMed Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G. Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr. 2006;19:356–63.CrossRefPubMed
8.
go back to reference Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int. 2014;86:489–96.CrossRefPubMed Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int. 2014;86:489–96.CrossRefPubMed
9.
go back to reference Katzarski KS. Monitoring of blood volume during haemodialysis treatment of acute renal and multiple organ failures. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1996;11(Suppl 8):20–3. Katzarski KS. Monitoring of blood volume during haemodialysis treatment of acute renal and multiple organ failures. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1996;11(Suppl 8):20–3.
10.
go back to reference Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int. 2006;69:1609–20.CrossRefPubMed Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int. 2006;69:1609–20.CrossRefPubMed
11.
go back to reference Charra B, Laurent G, Chazot C, Calemard E, Terrat JC, Vanel T, et al. Clinical assessment of dry weight. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1996;11(Suppl 2):16–9.CrossRef Charra B, Laurent G, Chazot C, Calemard E, Terrat JC, Vanel T, et al. Clinical assessment of dry weight. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1996;11(Suppl 2):16–9.CrossRef
12.
go back to reference Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006;26:118–33.CrossRefPubMed Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006;26:118–33.CrossRefPubMed
13.
go back to reference Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008;101:89E–103E.CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008;101:89E–103E.CrossRefPubMedPubMedCentral
14.
go back to reference Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883–9.CrossRefPubMed Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883–9.CrossRefPubMed
15.
go back to reference Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433–42.CrossRefPubMed Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433–42.CrossRefPubMed
16.
go back to reference Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–44.CrossRefPubMed Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–44.CrossRefPubMed
17.
go back to reference Kalantar-Zadeh K, Kovesdy CP, Derose SF, Horwich TB, Fonarow GC. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:493–506.CrossRefPubMed Kalantar-Zadeh K, Kovesdy CP, Derose SF, Horwich TB, Fonarow GC. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:493–506.CrossRefPubMed
18.
go back to reference Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial. 2007;20:549–53.CrossRefPubMed Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial. 2007;20:549–53.CrossRefPubMed
19.
go back to reference Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–9.CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–9.CrossRefPubMedPubMedCentral
20.
go back to reference • Zoccali, C, Moissl, U, Chazot, C, Mallamaci, F, Tripepi, G, Arkossy, O, Wabel, P, Stuard, S. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28:2491–7. Zoccali et al.’s recent JASN paper highlight mortality outcomes related to chronic fluid overload as measured by bioimpedance. This paper, in addition to Kalantar-Zadeh et al.’s 2009 “Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis” have well shown the association of chronic fluid overload with worse outcomes in HD patients. • Zoccali, C, Moissl, U, Chazot, C, Mallamaci, F, Tripepi, G, Arkossy, O, Wabel, P, Stuard, S. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28:2491–7. Zoccali et al.’s recent JASN paper highlight mortality outcomes related to chronic fluid overload as measured by bioimpedance. This paper, in addition to Kalantar-Zadeh et al.’s 2009 “Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis” have well shown the association of chronic fluid overload with worse outcomes in HD patients.
21.
go back to reference Agarwal R. What are the consequences of volume expansion in chronic dialysis patients?: hypertension as a manifestation of volume overload in hemodialysis patients. Semin Dial. 2015;28:231–2.CrossRefPubMed Agarwal R. What are the consequences of volume expansion in chronic dialysis patients?: hypertension as a manifestation of volume overload in hemodialysis patients. Semin Dial. 2015;28:231–2.CrossRefPubMed
23.
go back to reference Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5:254–66.CrossRefPubMedPubMedCentral Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5:254–66.CrossRefPubMedPubMedCentral
24.
go back to reference Martin LC, Franco RJ, Gavras I, Matsubara BB, Garcia S, Caramori JT, et al. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. Am J Hypertens. 2004;17:1163–9.CrossRefPubMed Martin LC, Franco RJ, Gavras I, Matsubara BB, Garcia S, Caramori JT, et al. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. Am J Hypertens. 2004;17:1163–9.CrossRefPubMed
25.
go back to reference Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004;65:1492–8.CrossRefPubMed Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004;65:1492–8.CrossRefPubMed
26.
go back to reference London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. Journal of the American Society of Nephrology : JASN. 2001;12:2759–67.PubMed London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. Journal of the American Society of Nephrology : JASN. 2001;12:2759–67.PubMed
27.
go back to reference Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. Journal of the American Society of Nephrology : JASN. 2000;11:912–6.PubMed Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. Journal of the American Society of Nephrology : JASN. 2000;11:912–6.PubMed
28.
go back to reference Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. J Nephrol. 2006;19:783–93.PubMed Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. J Nephrol. 2006;19:783–93.PubMed
29.
go back to reference Galetta F, Cupisti A, Franzoni F, Femia FR, Rossi M, Barsotti G, et al. Left ventricular function and calcium phosphate plasma levels in uraemic patients. J Intern Med. 2005;258:378–84.CrossRefPubMed Galetta F, Cupisti A, Franzoni F, Femia FR, Rossi M, Barsotti G, et al. Left ventricular function and calcium phosphate plasma levels in uraemic patients. J Intern Med. 2005;258:378–84.CrossRefPubMed
30.
go back to reference Elsayed ME, Stack AG. What are the consequences of volume expansion in chronic dialysis patients?: pulmonary manifestations of volume expansion. Semin Dial. 2015;28:235–9.CrossRefPubMed Elsayed ME, Stack AG. What are the consequences of volume expansion in chronic dialysis patients?: pulmonary manifestations of volume expansion. Semin Dial. 2015;28:235–9.CrossRefPubMed
31.
go back to reference Muir AL, Flenley DC, Kirby BJ, Sudlow MF, Guyatt AR, Brash HM. Cardiorespiratory effects of rapid saline infusion in normal man. J Appl Physiol. 1975;38:786–75.PubMed Muir AL, Flenley DC, Kirby BJ, Sudlow MF, Guyatt AR, Brash HM. Cardiorespiratory effects of rapid saline infusion in normal man. J Appl Physiol. 1975;38:786–75.PubMed
32.
go back to reference Prisk GK, Olfert IM, Arai TJ, Wagner PD, Hopkins SR. Rapid intravenous infusion of 20 ml/kg saline does not impair resting pulmonary gas exchange in the healthy human lung. J Appl Physiol (1985). 2010;108:53–9.CrossRef Prisk GK, Olfert IM, Arai TJ, Wagner PD, Hopkins SR. Rapid intravenous infusion of 20 ml/kg saline does not impair resting pulmonary gas exchange in the healthy human lung. J Appl Physiol (1985). 2010;108:53–9.CrossRef
33.
go back to reference Farney RJ, Morris AH, Gardner RM, Armstrong JD Jr. Rebreathing pulmonary capillary and tissue volume in normals after saline infusion. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:246–53.PubMed Farney RJ, Morris AH, Gardner RM, Armstrong JD Jr. Rebreathing pulmonary capillary and tissue volume in normals after saline infusion. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:246–53.PubMed
34.
go back to reference Watanabe T, Kobayashi T. Pleural calcification: a type of “metastatic calcification” in chronic renal failure. Br J Radiol. 1983;56:93–8.CrossRefPubMed Watanabe T, Kobayashi T. Pleural calcification: a type of “metastatic calcification” in chronic renal failure. Br J Radiol. 1983;56:93–8.CrossRefPubMed
35.
go back to reference Bakirci T, Sasak G, Ozturk S, Akcay S, Sezer S, Haberal M. Pleural effusion in long-term hemodialysis patients. Transplant Proc. 2007;39:889–91.CrossRefPubMed Bakirci T, Sasak G, Ozturk S, Akcay S, Sezer S, Haberal M. Pleural effusion in long-term hemodialysis patients. Transplant Proc. 2007;39:889–91.CrossRefPubMed
36.
go back to reference Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007;74:503–10.CrossRefPubMed Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007;74:503–10.CrossRefPubMed
37.
go back to reference Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). American journal of kidney diseases : the official journal of the National Kidney Foundation. 2007;49:426–31.CrossRef Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). American journal of kidney diseases : the official journal of the National Kidney Foundation. 2007;49:426–31.CrossRef
38.
go back to reference Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol. 2016;27:3758–68. Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol. 2016;27:3758–68.
39.
go back to reference •• Flythe JE, Assimon MM, Wenger JB, Wang L. Ultrafiltration rates and the quality incentive program: proposed measure definitions and their potential dialysis facility implications. Clinical journal of the American Society of Nephrology : CJASN. 2016;11:1422–33. Flythe et al.’s CJASN paper highlights the changing landscape in dialysis metrics regarding ultrafiltration rate and its associated outcomes. As currently in the United States, national HD metrics are starting to implement UFR cut-offs as part of patient quality initiatives. CrossRefPubMedPubMedCentral •• Flythe JE, Assimon MM, Wenger JB, Wang L. Ultrafiltration rates and the quality incentive program: proposed measure definitions and their potential dialysis facility implications. Clinical journal of the American Society of Nephrology : CJASN. 2016;11:1422–33. Flythe et al.’s CJASN paper highlights the changing landscape in dialysis metrics regarding ultrafiltration rate and its associated outcomes. As currently in the United States, national HD metrics are starting to implement UFR cut-offs as part of patient quality initiatives. CrossRefPubMedPubMedCentral
40.
go back to reference Flythe JE. Ultrafiltration rate clinical performance measures: ready for primetime? Semin Dial. 2016;29:425–34.CrossRefPubMed Flythe JE. Ultrafiltration rate clinical performance measures: ready for primetime? Semin Dial. 2016;29:425–34.CrossRefPubMed
41.
go back to reference Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69:1222–8.CrossRefPubMed Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69:1222–8.CrossRefPubMed
42.
go back to reference Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79:250–7.CrossRefPubMed Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79:250–7.CrossRefPubMed
43.
go back to reference Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clinical journal of the American Society of Nephrology : CJASN. 2009;4:914–20.CrossRefPubMedPubMedCentral Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clinical journal of the American Society of Nephrology : CJASN. 2009;4:914–20.CrossRefPubMedPubMedCentral
44.
go back to reference Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clinical journal of the American Society of Nephrology : CJASN. 2009;4:1925–31.CrossRefPubMedPubMedCentral Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clinical journal of the American Society of Nephrology : CJASN. 2009;4:1925–31.CrossRefPubMedPubMedCentral
45.
go back to reference McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation. 2004;109:3050–5.CrossRefPubMed McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation. 2004;109:3050–5.CrossRefPubMed
46.
go back to reference Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, et al. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens. 2006;24:1663–70.CrossRefPubMed Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, et al. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens. 2006;24:1663–70.CrossRefPubMed
47.
go back to reference Eldehni MT, McIntyre CW. Are there neurological consequences of recurrent intradialytic hypotension? Semin Dial. 2012;25:253–6.CrossRefPubMed Eldehni MT, McIntyre CW. Are there neurological consequences of recurrent intradialytic hypotension? Semin Dial. 2012;25:253–6.CrossRefPubMed
48.
go back to reference McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2011;6:133–41.CrossRefPubMedPubMedCentral McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG, et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2011;6:133–41.CrossRefPubMedPubMedCentral
49.
go back to reference Jefferies HJ, Crowley LE, Harrison LE, Szeto CC, Li PK, Schiller B, et al. Circulating endotoxaemia and frequent haemodialysis schedules. Nephron Clinical practice. 2014;128:141–6.CrossRefPubMed Jefferies HJ, Crowley LE, Harrison LE, Szeto CC, Li PK, Schiller B, et al. Circulating endotoxaemia and frequent haemodialysis schedules. Nephron Clinical practice. 2014;128:141–6.CrossRefPubMed
50.
go back to reference Marants R, Grant C, Lee T, McIntyre CW. Renal perfusion falls during hemodialysis: an explanation for the loss of residual renal function in dialysis patients. Journal of the American Society of Nephrology : JASN. 2016;27:Abstract Edition: 327A. Marants R, Grant C, Lee T, McIntyre CW. Renal perfusion falls during hemodialysis: an explanation for the loss of residual renal function in dialysis patients. Journal of the American Society of Nephrology : JASN. 2016;27:Abstract Edition: 327A.
51.
go back to reference Flythe JE, Mangione TW, Brunelli SM, Curhan GC. Patient-stated preferences regarding volume-related risk mitigation strategies for hemodialysis. Clinical journal of the American Society of Nephrology : CJASN. 2014;9:1418–25.CrossRefPubMedPubMedCentral Flythe JE, Mangione TW, Brunelli SM, Curhan GC. Patient-stated preferences regarding volume-related risk mitigation strategies for hemodialysis. Clinical journal of the American Society of Nephrology : CJASN. 2014;9:1418–25.CrossRefPubMedPubMedCentral
52.
go back to reference Agar JW. Personal viewpoint: limiting maximum ultrafiltration rate as a potential new measure of dialysis adequacy. Hemodialysis international International Symposium on Home Hemodialysis. 2016;20:15–21.CrossRefPubMed Agar JW. Personal viewpoint: limiting maximum ultrafiltration rate as a potential new measure of dialysis adequacy. Hemodialysis international International Symposium on Home Hemodialysis. 2016;20:15–21.CrossRefPubMed
54.
go back to reference Weinreich T, De los Rios T, Gauly A, Passlick-Deetjen J. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol. 2006;66:433–9.CrossRefPubMed Weinreich T, De los Rios T, Gauly A, Passlick-Deetjen J. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol. 2006;66:433–9.CrossRefPubMed
55.
go back to reference Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, et al. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens. 2007;25:1285–9.CrossRefPubMed Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, et al. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens. 2007;25:1285–9.CrossRefPubMed
56.
go back to reference Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003;42:13–7.CrossRef Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003;42:13–7.CrossRef
57.
go back to reference Dorairajan S, Chockalingam A, Misra M. Myocardial stunning in hemodialysis: what is the overall message? Hemodialysis international International Symposium on Home Hemodialysis. 2010;14:447–50.CrossRefPubMed Dorairajan S, Chockalingam A, Misra M. Myocardial stunning in hemodialysis: what is the overall message? Hemodialysis international International Symposium on Home Hemodialysis. 2010;14:447–50.CrossRefPubMed
58.
go back to reference McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease. Blood Purif. 2010;29:105–10.CrossRefPubMed McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease. Blood Purif. 2010;29:105–10.CrossRefPubMed
59.
go back to reference Chou, JA, Streja, E, Nguyen, DV, Rhee, CM, Obi, Y, Inrig, JK, Amin, A, Kovesdy, CP, Sim, JJ, Kalantar-Zadeh, K. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients. Nephrol Dial Transplant. 2017. https://doi.org/10.1093/ndt/gfx037. Chou, JA, Streja, E, Nguyen, DV, Rhee, CM, Obi, Y, Inrig, JK, Amin, A, Kovesdy, CP, Sim, JJ, Kalantar-Zadeh, K. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients. Nephrol Dial Transplant. 2017. https://​doi.​org/​10.​1093/​ndt/​gfx037.
60.
go back to reference Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. Journal of the American Society of Nephrology : JASN. 2015;26:724–34.CrossRefPubMed Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. Journal of the American Society of Nephrology : JASN. 2015;26:724–34.CrossRefPubMed
Metadata
Title
Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient
Authors
Jason A. Chou
Kamyar Kalantar-Zadeh
Publication date
01-10-2017
Publisher
Springer US
Published in
Current Heart Failure Reports / Issue 5/2017
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-017-0356-6

Other articles of this Issue 5/2017

Current Heart Failure Reports 5/2017 Go to the issue

Management of Heart Failure (T Meyer, Section Editor)

Vitamin D and Heart Failure

Decompensated Heart Failure (P Banerjee, Section Editor)

Mechanical Circulatory Support for Decompensated Heart Failure

Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors)

Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction

Decompensated Heart Failure (P Banerjee, Section Editor)

Acute Heart Failure: Definition, Classification and Epidemiology

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (A Hasan, Section Editor)

Updates in Cardiac Resynchronization Therapy for Chronic Heart Failure: Review of Multisite Pacing

Pathophysiology of Myocardia Failure (I Anand and M Patarroyo-Aponte, Section Editors)

Prevention of Chemotherapy Induced Cardiomyopathy

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.